RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer

Published:2019-01-28 Issue:20 Volume:38 Page:3903-3918
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Kim Bo Ram,Park Seong Hye,Jeong Yoon A,Na Yoo Jin,Kim Jung Lim,Jo Min Jee,Jeong Soyeon,Yun Hye Kyeong,Oh Sang Cheul,Lee Dae-Hee

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0693-x.pdf

Reference61 articles.

1. Pan G, O’Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al. The receptor for the cytotoxic ligand TRAIL. Science. 1997;276:111–3.

2. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 1997;16:5386–97.

3. Yang F, Tay KH, Dong L, Thorne RF, Jiang CC, Yang E, et al. Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L) from degradation by the E3 ligase itch in human melanoma cells. Cell Death Differ. 2010;17:1354–67.

4. Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer. 2008;8:782–98.

5. Na YJ, Lee DH, Kim JL, Kim BR, Park SH, Jo MJ, et al. Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation. Int J Biochem Cell Biol. 2017;89:147–56.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer;Biomaterials;2025-01

2. Rolapitant treats lung cancer by targeting deubiquitinase OTUD3;Cell Communication and Signaling;2024-03-27

3. Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma;Journal of Translational Medicine;2024-02-29

4. Application of calcium overload-based ion interference therapy in tumor treatment: strategies, outcomes, and prospects;Frontiers in Pharmacology;2024-02-15

5. Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy;Cell Communication and Signaling;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3